American Journal of Kidney Diseases

Effect of Lowering Dialysate Sodium Concentration on Interdialytic Weight Gain and Blood Pressure in Patients Undergoing Thrice-Weekly In-center Nocturnal Hemodialysis: A Quality Improvement Study

Published:August 29, 2011DOI:


      Patients on in-center nocturnal hemodialysis therapy typically experience higher interdialytic weight gain (IDWG) than patients on conventional hemodialysis therapy. We determined the safety and effects of decreasing dialysate sodium concentration on IDWG and blood pressure in patients on thrice-weekly in-center nocturnal hemodialysis therapy.

      Study Design

      Quality improvement, pre-post intervention.

      Settings & Participants

      15 participants in a single facility.

      Quality Improvement Plan

      Participants underwent three 12-week treatment phases, each with different dialysate sodium concentrations, as follows: phase A, 140 mEq/L; phase B, 136 or 134 mEq/L; and phase A+, 140 mEq/L. Participants were blinded to the exact timing of the intervention.


      IDWG, IDWG/dry weight (IDWG%), and blood pressure.


      Outcome data were obtained during the last 2 weeks of each phase and compared with mixed models. The fraction of sessions with adverse events (eg, cramping and hypotension) also was reported.


      IDWG, IDWG%, and predialysis systolic blood pressure decreased significantly by 0.6 ± 0.6 kg, 0.6% ± 0.8%, and 8.3 ± 14.9 mm Hg, respectively, in phase B compared with phase A (P < 0.05 for all comparisons). No differences in predialysis diastolic and mean arterial or postdialysis blood pressures were found (P > 0.05 for all comparisons). The proportion of treatments with intradialytic hypotension was low and similar in each phase (P = 0.9). In phase B compared with phase A, predialysis plasma sodium concentration was unchanged (P > 0.05), whereas postdialysis plasma sodium concentration decreased by 3.7 ± 1.9 mEq/L (P < 0.05).


      Modest sample size.


      Decreasing dialysate sodium concentrations in patients undergoing thrice-weekly in-center nocturnal hemodialysis resulted in a clinical and statistically significant decrease in IDWG, IDWG%, postdialysis plasma sodium concentration, and predialysis systolic blood pressure without increasing adverse events. Prolonged exposure to higher than required dialysate sodium concentrations may drive IDWG and counteract some of the purported benefits of “go-slow” (longer session length) hemodialysis.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Holmberg B.
        • Stegmayr B.G.
        Cardiovascular conditions in hemodialysis patients may be worsened by extensive interdialytic weight gain.
        Hemodial Int. 2009; 13: 27-31
        • Kalantar-Zadeh K.
        • Regidor D.L.
        • Kovesdy C.P.
        • et al.
        Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis.
        Circulation. 2009; 119: 671-679
        • Saran R.
        • Bragg-Gresham J.L.
        • Rayner H.C.
        • et al.
        Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS.
        Kidney Int. 2003; 64: 254-262
        • Leggat Jr, J.E.
        • Orzol S.M.
        • Hulbert-Shearon T.E.
        • et al.
        Noncompliance in hemodialysis: predictors and survival analysis.
        Am J Kidney Dis. 1998; 32: 139-145
        • Foley R.N.
        • Herzog C.A.
        • Collins A.J.
        Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study.
        Kidney Int. 2002; 62: 1784-1790
        • Nesrallah G.
        • Suri R.
        • Moist L.
        • Kortas C.
        • Lindsay R.M.
        Volume control and blood pressure management in patients undergoing quotidian hemodialysis.
        Am J Kidney Dis. 2003; 42: 13-17
        • Troidle L.
        • Hotchkiss M.
        • Finkelstein F.
        A thrice weekly in-center nocturnal hemodialysis program.
        Adv Chronic Kidney Dis. 2007; 14: 244-248
        • Lacson Jr, E.
        • Wang W.
        • Lester K.
        • Ofsthun N.
        • Lazarus J.M.
        • Hakim R.M.
        Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program.
        Clin J Am Soc Nephrol. 2010; 5: 220-226
        • Penne E.L.
        • Levin N.W.
        • Kotanko P.
        Improving volume status by comprehensive dietary and dialytic sodium management in chronic hemodialysis patients.
        Blood Purif. 2010; 30: 71-78
        • Pozzoni P.
        • DI Filippo S.
        • Pontoriero G.
        • Locatelli F.
        Effectiveness of sodium and conductivity kinetic models in predicting end-dialysis plasma water sodium concentration: preliminary results of a single-center experience.
        Hemodial Int. 2007; 11: 169-177
        • Kimura G.
        • Van Stone J.C.
        • Bauer J.H.
        • Keshaviah P.R.
        A simulation study on transcellular fluid shifts induced by hemodialysis.
        Kidney Int. 1983; 24: 542-548
        • Flanigan M.J.
        • Khairullah Q.T.
        • Lim V.S.
        Dialysate sodium delivery can alter chronic blood pressure management.
        Am J Kidney Dis. 1997; 29: 383-391
        • Peixoto A.J.
        • Gowda N.
        • Parikh C.R.
        • Santos S.F.
        Long-term stability of serum sodium in hemodialysis patients.
        Blood Purif. 2010; 29: 264-267
        • Keen M.L.
        • Gotch F.A.
        The association of the sodium “setpoint” to interdialytic weight gain and blood pressure in hemodialysis patients.
        Int J Artif Organs. 2007; 30: 971-979
        • de Paula F.M.
        • Peixoto A.J.
        • Pinto L.V.
        • Dorigo D.
        • Patricio P.J.
        • Santos S.F.
        Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients.
        Kidney Int. 2004; 66: 1232-1238
        • Santos S.F.
        • Peixoto A.J.
        Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients.
        Clin J Am Soc Nephrol. 2008; 3: 522-530
        • Flanigan M.J.
        Role of sodium in hemodialysis.
        Kidney Int Suppl. 2000; 76: S72-S78
        • Flanigan M.
        Dialysate composition and hemodialysis hypertension.
        Semin Dial. 2004; 17: 279-283
        • Sayarlioglu H.
        • Erkoc R.
        • Tuncer M.
        • et al.
        Effects of low sodium dialysate in chronic hemodialysis patients: an echocardiographic study.
        Ren Fail. 2007; 29: 143-146
        • Charra B.
        From adequate to optimal dialysis long 3 × 8 hr dialysis: a reasonable compromise.
        Nefrologia. 2005; 25: 19-24
        • Lambie S.H.
        • Taal M.W.
        • Fluck R.J.
        • McIntyre C.W.
        Online conductivity monitoring: validation and usefulness in a clinical trial of reduced dialysate conductivity.
        ASAIO J. 2005; 51: 70-76
        • Flanigan M.J.
        How should dialysis fluid be individualized for the chronic hemodialysis patient?.
        Semin Dial. 2008; 21: 226-229
        • Depner T.A.
        • Ing T.S.
        Toxic fluid flux?.
        Am J Kidney Dis. 2010; 56: 1-4
        • Moret K.E.
        • Beerenhout C.H.
        • Kooman J.P.
        Variations in predialytic plasma conductivity in dialysis patients: effect on ionic mass balance and blood pressure.
        ASAIO J. 2011; 57: 53-61
        • Manlucu J.
        • Gallo K.
        • Heidenheim P.A.
        • Lindsay R.M.
        Lowering postdialysis plasma sodium (conductivity) to increase sodium removal in volume-expanded hemodialysis patients: a pilot study using a biofeedback software system.
        Am J Kidney Dis. 2010; 56: 69-76
        • Shaldon S.
        • Vienken J.
        The long forgotten salt factor and the benefits of using a 5-g-salt-restricted diet in all ESRD patients.
        Nephrol Dial Transplant. 2008; 23: 2118-2120
        • Charra B.
        • Bergstrom J.
        • Scribner B.H.
        Blood pressure control in dialysis patients: importance of the lag phenomenon.
        Am J Kidney Dis. 1998; 32: 720-724
        • Shaldon S.
        An explanation for the “lag phenomenon” in drug-free control of hypertension by dietary salt restriction in patients with chronic kidney disease on hemodialysis.
        Clin Nephrol. 2006; 66: 1-2
        • Luik A.J.
        • Charra B.
        • Katzarski K.
        • et al.
        Blood pressure control and hemodynamic changes in patients on long time dialysis treatment.
        Blood Purif. 1998; 16: 197-209
        • Titze J.
        Water-free sodium accumulation.
        Semin Dial. 2009; 22: 253-255
        • Daugirdas J.T.
        • Al-Kudsi R.R.
        • Ing T.S.
        • Norusis M.J.
        A double-blind evaluation of sodium gradient hemodialysis.
        Am J Nephrol. 1985; 5: 163-168
        • Thein H.
        • Haloob I.
        • Marshall M.R.
        Associations of a facility level decrease in dialysate sodium concentration with blood pressure and interdialytic weight gain.
        Nephrol Dial Transplant. 2007; 22: 2630-2639
        • Inrig J.K.
        • Patel U.D.
        • Gillespie B.S.
        • et al.
        Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients.
        Am J Kidney Dis. 2007; 50 (118 e101-104): 108-118
        • Basile C.
        • Giordano R.
        • Vernaglione L.
        • et al.
        Efficacy and safety of haemodialysis treatment with the Hemocontrol biofeedback system: a prospective medium-term study.
        Nephrol Dial Transplant. 2001; 16: 328-334
        • Lamb E.J.
        • Abbas N.A.
        Spurious hypernatraemia and Citra-Lock.
        Ann Clin Biochem. 2007; 44: 579